Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Acta Parasitologica

4 Issues per year

IMPACT FACTOR 2017: 1.039
5-year IMPACT FACTOR: 1.121

CiteScore 2017: 1.17

SCImago Journal Rank (SJR) 2017: 0.641
Source Normalized Impact per Paper (SNIP) 2017: 0.738

See all formats and pricing
More options …
Volume 60, Issue 4


Malondialdehyde; Lipid peroxidation plasma biomarker correlated with hepatic fibrosis in human Schistosoma mansoni infection

Inas Abdel Aziz
  • Corresponding author
  • Faculty of Medicine, Cairo University Kasr AlAiny street, Kasr AlAiny School of Medicine, Cairo University Hospitals, Cairo, 11562, Egypt. Departments: Medical Parasitology
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mariam Yacoub
  • Faculty of Medicine, Cairo University Kasr AlAiny street, Kasr AlAiny School of Medicine, Cairo University Hospitals, Cairo, 11562, Egypt. Departments: Clinical & Chemical Pathology
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Laila Rashid
  • Faculty of Medicine, Cairo University Kasr AlAiny street, Kasr AlAiny School of Medicine, Cairo University Hospitals, Cairo, 11562, Egypt. Departments: Medical Biochemistry
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ahmad Solieman
  • Faculty of Medicine, Cairo University Kasr AlAiny street, Kasr AlAiny School of Medicine, Cairo University Hospitals, Cairo, 11562, Egypt. Departments: Tropical Medicine
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2015-09-25 | DOI: https://doi.org/10.1515/ap-2015-0105


Schistosomiasis is a debilitating parasitic disease, affects large number of host species. Currently affects 250-300 million people in tropic areas. Schistosoma pathogenic impact is hepatic periportal fibrosis; the parasite-induced inflammatory cellular activation promotes oxidative stress, resulting in lipid peroxidation (LPO), with subsequent increase in inflammatory mediators as malondialdehyde (MDA). This study was set up to reveal possible contribution of lipid peroxidation byproducts MDA in hepatic pathophysiology. Results displayed that MDA don’t tend to change in relation with either age, nor hepatic transaminases AST & ALT, while exhibited a significant increase in MDA levels in human schistosomiasis versus control group P<0.0001 (Mn. ± St.dev. 7.77 ± 3.59, 1.21 ± 0.28 nmol/ml) respectively. Moreover; MDA plasma levels in Schistosoma infected group correlated significantly with two hepatic fibrosis parameters; (a) ultrasonography graded periportal fibrosis P< 0.0001. Levels of MDA in hepatic fibrosis grades 0, I, II, III in Schistosoma infected group were (Mn. ± St.dev. 2.8 ± 0.64, 4.3 ± 1.2, 9.3 ± 1.6 and 10.8 ± 1.3 nmol/ml) respectively, (b) serum Hyaluronic acid (HA) P<0.0001 (spearman r = 0.77) as a reliable hepatic fibrosis marker. This implies a considerable role of LPO byproducts in schistosomiasis pathogenicity, and proposing malondialdehyde as a biomarker for schistosomiasis morbidity.

Keywords: Lipid peroxidation; Malondialdehyd; Schistosoma mansoni; Hyaluronic acid


  • Abdallahi O.M., Hanna S., De Reggi M., Gharib B. 1999. Visualization of oxygen radical production in mouse liver in response to infection with Schistosoma mansoni. Liver, 19, 495-500Google Scholar

  • Abou-El-Naga I.F., 2013. Biomphalaria alexandrina in Egypt: Past, present and future. Journal of Biosciences, 38, 665-672. DOI: 10.1007/s12038-013-9329-4CrossrefWeb of ScienceGoogle Scholar

  • Barros A.F., Oliveira S.A., Carvalho C.L., Silva F.L., de Souza V.A., Da Silva A.L., De Araujo R.E., Souza, B., S., Soares M.B.P., Costa V.M., Coutinho E.D. 2014. Low transformation growth factor-β1 production and collagen synthesis correlate with the lack of hepatic periportal fibrosis development in undernourished mice infected with Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz, 109, 210-219. DOI: 10.1590/0074-0276140266Web of ScienceCrossrefGoogle Scholar

  • Coutinho E.M., Silva F.L., Barros A.F., Araujo R.E., Oliveira S.A.L., Carlos F.B., Aryon A.A., Zilton A. 2007. Repeated infections with Schistosoma mansoni and liver fibrosis in undernourished mice. Acta Tropica, 101, 15-24. DOI: 10.1016/j.actatropica.2006.03.006CrossrefWeb of ScienceGoogle Scholar

  • Coutinho H.M., McGarvey S.T., Acosta L.P., Manalo D.L., Langdon G.C., Leenstra T., Kanzaria H.K., Solomon J., Wu H., Olveda R., Kurtis J.D., Friedman J.F. 2005. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. The Journal of Infectious Diseases, 192, 528-36. DOI: 10.1086/430929CrossrefGoogle Scholar

  • Cunha G.M., Silva V.M.A., Bessa K.D.G., Bitencourt M.A.O., Macedo U.B.O., Freire-Neto F.P., Martins R.R., Assis C.F., Lemos T.M.A.M., Almeida M.G., Freire A.C.G. 2012. Levels of oxidative stress markers: correlation with hepatic function and worm burden patients with schistosomiasis. Acta Parasitologica, 57, 160-166. DOI: 10.2478/s11686-012-0026-5Web of ScienceCrossrefGoogle Scholar

  • Dessein A.J., Marquet S., Henri S., E.l., Wali N.E., Hillaire D., Rodrigues V., Prata A., Ali Q.M., Gharib, B., de Reggi M., Magzoub M.M., Saeed O.K., Abdelhameed A.A., Abel L. 1999. Infection and disease in human schistosomiasis mansoni are under distinct major gene control. Microbes and Infection, 1, 561-567Google Scholar

  • Domingues A.L.C., Medeiros T.B., Lopes E.P. de A. 2011. Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz, 106, 802-807Web of ScienceGoogle Scholar

  • Eboumbou C., Steghens J.P., Abdallahi O.M.S., Mirghani A., Gallian P., van Kappel A., Qurashi A., Gharib B., De Reggi M. 2005. Circulating markers of oxidative stress and liver fibrosis in Sudanese subjects at risk of schistosomiasis and hepatitis. Acta Tropica, 94, 99-106. DOI: 10.1016/j.actatropica.2005.03.001CrossrefGoogle Scholar

  • Elsammak M.Y., Al-Sharkaweey R.M., Ragab M.S., Amin G.A., Kandil M.H. 2008. IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease. Parasite Immunology, 30, 603-609. DOI: 10.1111/ j.1365-3024.2008.01061.x Esterbauer H., Schaur R.J., Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine, 11, 81-128CrossrefGoogle Scholar

  • Esterbauer H. 1993. Cytotoxicity and genotoxicity of lipid-oxidation products. The American Journal of Clinical Nutrition, 57, 779S-785S Google Scholar

  • Facundo H.T.F., Brandt C.T., Owen J.S., Lima V.L.M. 2004. Elevated levels of erythrocyte-conjugated dienes indicate increased lipid peroxidation in schistosomiasis mansoni patients. Brazilian Journal Of Medical and Biological Research, 37, 957-962. DOI: /S0100-879X2004000700003Google Scholar

  • Gil L., Siems W., Mazurek B., Gross J., Schroeder P., Voss P., Grune T. 2006. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res, 40, 495-505. DOI: 10.1080/10715760600592962CrossrefGoogle Scholar

  • Gordon C.C., and Alimuddin I.Z. 2003. Manson’s Tropical Diseases. W.B. Saunders, USA, PhiladelphiaGoogle Scholar

  • Grigorescu M., 2006. Noninvasive Biochemical Markers of Liver Fibrosis. Journal of Gastrointestinal and Liver Diseases, 15, 149-159Google Scholar

  • Gutteridge J.M., Halliwell B. 1990. The measurement and mechanism of lipid peroxidation in biological systems. Trends in Biochemical Sciences, 15, 129-135Google Scholar

  • Halfon P., Bourliere M., Penaranda G., Deydier R., Renou C., Botta- Fridlund D., Tran A., Portal I., Allemand I., Rosenthal-Allieri A., Ouzan D. 2005. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comparative Hepatology, 4, 6. DOI: 10.1186/1476-5926-4-6CrossrefGoogle Scholar

  • Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Ehrlich Sachs S., Sachs Je. D. 2006. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med, 3, e102. DOI: 10. 1371/journal.pmed.0030102CrossrefWeb of ScienceGoogle Scholar

  • King C.H., Dickman K., Tisch D.J. 2005. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disabilityrelated outcomes in endemic schistosomiasis. Lancet, 365, 1561-1569. DOI: 10.1016/S0140-6736(05)66457-4CrossrefGoogle Scholar

  • Köpke-Aguiar L., Martins J.R., Passerotti C., Toledo C.F., Nader H.B., Borges D.R. 2002. Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schistosomiasis. Acta Tropica, 84, 117-126. DOI: 10.1016/S0001-706X(02)00136-5CrossrefGoogle Scholar

  • Lefèvre G., Beljean-Leymarie M., Beyerle F., Bonnefont-Rousselot D., Cristol J.P., Thérond P., Torreilles J. 1998. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Annales De Biologie Clinique (Paris), 56, 305-319Google Scholar

  • Maia M.D., Lopes E.P.A., Ferraz A.A.B., Barros, Fábio M.R., Domingues A.L.C., Ferraz E.M. 2007. Evaluation of splenomegaly in the hepatosplenic form of mansonic schistosomiasis. Acta Tropica, 101, 183-186. DOI: 10.1016/j.actatropica.2007.01.004CrossrefWeb of ScienceGoogle Scholar

  • Marnett L.J. 2000. Oxyradicals and DNA damage. Carcinogenesis, 21, 361-370. DOI:10.1093/carcin /21.3.361CrossrefGoogle Scholar

  • Mendoza-Núñez V.M., Ruiz-Ramos M., Sánchez-Rodríguez M., Retana- Ugalde R., Muñoz-Sánchez J.L. 2007. Aging-related oxidative stress in healthy humans. Tohoku Journal of Experimental Medicine, 213, 261-268. DOI: 10.1620/tjem.213.261CrossrefGoogle Scholar

  • Nielsen F., Mikkelsen B.B., Nielsen J.B., Andersen H.R. 1997. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clinical Chemistry, 1214, 1209-1214Google Scholar

  • Pearce E.J., MacDonald A.S. 2002. The immunobiology of schistosomiasis. Nature Reviews Immunology, 2, 499-511. DOI: 10.1038/nri843 CrossrefGoogle Scholar

  • Pontinha N., Pessegueiro H., Barros H. 1999. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scandinavian Journal of Clinical and Laboratory Investigation, 59 343-347Google Scholar

  • Richter J., Lúcia A., Domingues C., Barata C.H., Prata A.R., Lambertucci J.R., 2001. Report of the Second Satellite Symposium on Ultrasound in Schistosomiasis. Memórias do Instituto Oswaldo Cruz, 96, 151-156Google Scholar

  • Richter J., 2000. Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Tropica, 77, 111-131Google Scholar

  • Santos V.N. dos., Leite-Mór M.M.B., Kondo M., Martins J.R., Nader H., Lanzoni V.P., Parise E.R. 2005. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Brazilian Journal Of Medical and Biological Research, 38, 747-753. DOI: 10.1590/S0100-879X200 5000500012CrossrefGoogle Scholar

  • Sies H., Cadenas E., Symons M.C.R., Scott G., 1985. Oxidative Stress: Damage to Intact Cells and Organs [and Discussion]. Philosophical Transactions of the Royal Society B: Biological Sciences, 311, 617-631. DOI: 10.1098/rstb.1985.0168CrossrefGoogle Scholar

  • Taccone-Gallucci M., Lubrano R., Meloni C., Morosetti M., Adolfo C.M.C.C. 1998. Malonyldialdehyde content of cell membranes is the most important marker of oxidative stress in haemodialysis patients. Nephrology Dialysis Transplantation, Oct; 13, 2711-2712Google Scholar

  • Vanheule E., Geerts A.M., Van Huysse J., Schelfhout D., Praet M., Van Vlierberghe H., De Vos M., Colle I. 2008. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. International Journal of Experimental Pathology, 89, 419-432. DOI: 10.1111/j.1365-2613.2008.00608.x CrossrefWeb of ScienceGoogle Scholar

  • Zhou X.N., Wang L.Y., Chen M.G., Wu X.H., Jiang Q.W., Chen X.Y., Zheng J. Utzinger J. 2005. The public health significance and control of schistosomiasis in China-then and now. Acta Tropica, 96, 97-105. DOI: 10.1016/j.actatropica.2005.07.005 CrossrefGoogle Scholar

About the article

Received: 2014-12-13

Revised: 2015-05-29

Accepted: 2015-06-01

Published Online: 2015-09-25

Published in Print: 2015-12-01

Citation Information: Acta Parasitologica, Volume 60, Issue 4, Pages 735–742, ISSN (Online) 1896-1851, ISSN (Print) 1230-2821, DOI: https://doi.org/10.1515/ap-2015-0105.

Export Citation

W. Stefański Institute of Parasitology, PAS.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Esam M. Aboubakr, Ashraf Taye, Omar M. Aly, Amira M. Gamal-Eldeen, and Mohamed A. El-Moselhy
Biomedicine & Pharmacotherapy, 2017, Volume 89, Page 36
Lijun Chen, Yuan Li, Wenqin Yin, Wenqi Shan, Jinfeng Dai, Ye Yang, and Lei Li
Environmental Toxicology and Pharmacology, 2016, Volume 46, Page 255
Majid Mirmoghaddam, Massoud Kaykhaii, and Mohammad Hashemi
Anal. Methods, 2016, Volume 8, Number 11, Page 2456
Shanting Liao, Pei Li, Junsong Wang, Qian Zhang, Dingqiao Xu, Minghua Yang, and Lingyi Kong
Toxicol. Res., 2016, Volume 5, Number 4, Page 1148

Comments (0)

Please log in or register to comment.
Log in